Sulfonylureas: Scoring beyond START STUDY. - Wikidata - awgldk - TriplyDB

Sulfonylureas: Scoring beyond START STUDY.

Sulfonylureas: Scoring beyond START STUDY.

http://www.wikidata.org/entity/Q47108935

about

Sulfonylureas: Scoring beyond START STUDY.

http://www.wikidata.org/entity/Q47108935

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Sulfonylureas: Scoring beyond START STUDY.

@en

Sulfonylureas: Scoring beyond START STUDY.

@nl

type

label

Sulfonylureas: Scoring beyond START STUDY.

@en

Sulfonylureas: Scoring beyond START STUDY.

@nl

prefLabel

Sulfonylureas: Scoring beyond START STUDY.

@en

Sulfonylureas: Scoring beyond START STUDY.

@nl

P1433

Q47108935-C5200FD3-831C-4948-99F9-BB903AA40593

P1476

Q47108935-B6715E06-A0E0-44DD-A615-6E98F8B98BAF

P2093

Q47108935-1FC6BFC8-2DC9-4CEB-A64E-A619CEF57C32

P2860

Q47108935-2881EDC2-5ECD-40DC-8B7F-B644F7F16E4B

Q47108935-2B367C93-A07D-407D-BCA6-6F6C8812B9CE

Q47108935-5D8EC68E-EBF8-4E10-8F16-0CEA8F1E9AA6

Q47108935-5FCA8CA5-5AE1-4821-975B-BD41D4CA51C6

Q47108935-6DBD3B57-B81C-4ABE-B620-03A21993FD98

Q47108935-85567849-B4B2-44C3-BB89-EB598F009367

Q47108935-9C751811-DF38-40B8-92E3-E41B64B9E747

Q47108935-CC2727E4-BD5B-431E-94E4-9FC1A9A95CE7

P304

Q47108935-B61700A8-0F41-4636-A9BF-89F1FE55C35C

P31

Q47108935-E30A7204-0C09-456A-A709-FF2F106881B2

P356

Q47108935-65351DB2-DF83-4233-958C-45AF45F54992

P433

Q47108935-E97E70DD-5071-467F-9ADE-55A5694FDBF1

P478

Q47108935-DDFC8363-38BE-4814-8DEA-71F02A575F98

P577

Q47108935-619F8223-42A0-42DB-8266-46E7273F30AA

P698

Q47108935-A2B35F34-FE80-4018-863B-B8B5BECF2C62

P932

Q47108935-4EEBCE0D-26B7-4933-A57F-7F75D6D36878

P356

IJEM.IJEM_322_17

P1433

Indian Journal of Endocrinology and Metabolism

P1476

Sulfonylureas: Scoring beyond START STUDY.

@en

P2093

Altamash Shaikh

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanism by which metformin reduces glucose production in type 2 diabetes

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data.

Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta-analysis.

Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials.

Determinants of Glycemic Response to Add-On Therapy with a Dipeptidyl Peptidase-4 Inhibitor: A Retrospective Cohort Study Using a United Kingdom Primary Care Database.

Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study.

P304

928-929

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/IJEM.IJEM_322_17

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285461

http://www.w3.org/2001/XMLSchema#string

P932

5729686

http://www.w3.org/2001/XMLSchema#string